Mark Tengler
Amministratore Delegato presso Spectrix Therapeutics LLC
Posizioni attive di Mark Tengler
Società | Posizione | Inizio | Fine |
---|---|---|---|
Spectrix Therapeutics LLC
Spectrix Therapeutics LLC Pharmaceuticals: MajorHealth Technology Spectrix Therapeutics LLC is a privately held specialty pharmaceutical company. It provide and develops St-ME01, and ST-RHU02. The company was founded by Mark Tengler, John Q. Adams Jr., and John Dyett in 2016 and is headquartered in Southlake, TX. | Amministratore Delegato | 01/01/2016 | - |
Fondatore | 01/01/2016 | - |
Storia della carriera di Mark Tengler
Precedenti posizioni note di Mark Tengler
Società | Posizione | Inizio | Fine |
---|---|---|---|
NEOS THERAPEUTICS, INC. | Direttore Tecnico/Scientifico/R&S | 11/05/2011 | 01/03/2016 |
Presidente | 15/06/2009 | - | |
PharmaPrint, Inc.
PharmaPrint, Inc. BiotechnologyHealth Technology PharmaPrint, Inc. develops dietary supplements, functional foods, and pharmaceutical products from botanical sources. The private company is based in Irvine, CA. | Direttore operativo | - | - |
Formazione di Mark Tengler
Colorado State University | Undergraduate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 5 |
Posizioni
Chief Tech/Sci/R&D Officer | 1 |
President | 1 |
Undergraduate Degree | 1 |
Settori
Health Technology | 4 |
Consumer Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Aziende private | 3 |
---|---|
PharmaPrint, Inc.
PharmaPrint, Inc. BiotechnologyHealth Technology PharmaPrint, Inc. develops dietary supplements, functional foods, and pharmaceutical products from botanical sources. The private company is based in Irvine, CA. | Health Technology |
Neos Therapeutics, Inc.
Neos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Neos Therapeutics, Inc is a pharmaceutical company focused on developing, manufacturing and commercializing products utilizing its proprietary modified-release drug delivery technology platforms. Its products are Adzenys XR-ODT (amphetamine), Cotempla XR-ODT (methylphenidate), and Adzenys-ER (amphetamine) extended-release oral suspension, all for the treatment of ADHD, are the first three approved products using the Company's extended-release technology platform. The firm manufactures and markets its generic version of the branded product Tussionex, an extended-release oral suspension of hydrocodone and chlorpheniramine for the relief of cough and upper respiratory symptoms of a cold. The company was founded by Darlene R. Ryan on November 30, 1994 and is headquartered in Grand Prairie, TX. | Health Technology |
Spectrix Therapeutics LLC
Spectrix Therapeutics LLC Pharmaceuticals: MajorHealth Technology Spectrix Therapeutics LLC is a privately held specialty pharmaceutical company. It provide and develops St-ME01, and ST-RHU02. The company was founded by Mark Tengler, John Q. Adams Jr., and John Dyett in 2016 and is headquartered in Southlake, TX. | Health Technology |
- Borsa valori
- Insiders
- Mark Tengler
- Esperienza